SCHEMBL26017124

SCHEMBL26017124

Cc1ccc(-c2n(C)c3ccccc3[n+]2C)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERAP1 Q9NZ08 1/20 0.50
KDM4E B2RXH2 5/20 0.49
MAPT P10636 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 4/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
POLB P06746 1/20 0.38
PTPN1 P18031 1/20 0.37
NTRK1 P04629 1/20 0.36
TP53 P04637 1/20 0.35
NPC1 O15118 2/20 0.35
XDH P47989 1/20 0.35
MEN1 O00255 1/20 0.34
NR1I2 O75469 1/20 0.34
AHR P35869 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26017105 0.89 ERAP1 (0.49) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL13173905 0.85 ERAP1 (0.54) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL25776496 0.85 ERAP1 (0.48) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL26017130 0.84 ERAP1 (0.47) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL26017131 0.84 ERAP1 (0.54) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL26018412 0.83 ERAP1 (0.39) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL26018047 0.83 ERAP1 (0.39) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL15320330 0.83 ERAP1 (0.51) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL26017291 0.82 PTPN1 (0.34) ERAP1KDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL26017212 0.82 PTPN1 (0.34) ERAP1KDM4EMAPTL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound ORC3, LAGE3, ORMDL3 ERAP1 4289/4885KDM4E 2863/4885MAPT 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.